JP2021526834A5 - - Google Patents
Info
- Publication number
- JP2021526834A5 JP2021526834A5 JP2020569147A JP2020569147A JP2021526834A5 JP 2021526834 A5 JP2021526834 A5 JP 2021526834A5 JP 2020569147 A JP2020569147 A JP 2020569147A JP 2020569147 A JP2020569147 A JP 2020569147A JP 2021526834 A5 JP2021526834 A5 JP 2021526834A5
- Authority
- JP
- Japan
- Prior art keywords
- sequence
- sequence number
- recombinant aav2
- aav2 vector
- vector according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862683501P | 2018-06-11 | 2018-06-11 | |
| US62/683,501 | 2018-06-11 | ||
| PCT/US2019/036487 WO2019241206A1 (en) | 2018-06-11 | 2019-06-11 | Recombinant aav vectors and methods of using the same |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021526834A JP2021526834A (ja) | 2021-10-11 |
| JP2021526834A5 true JP2021526834A5 (https=) | 2022-06-15 |
| JP7470057B2 JP7470057B2 (ja) | 2024-04-17 |
Family
ID=67138055
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020569147A Active JP7470057B2 (ja) | 2018-06-11 | 2019-06-11 | 組み換えａａｖベクター及びその使用方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20210189424A1 (https=) |
| EP (1) | EP3802840A1 (https=) |
| JP (1) | JP7470057B2 (https=) |
| KR (1) | KR102946006B1 (https=) |
| CN (1) | CN112384625A (https=) |
| AU (1) | AU2019286386B2 (https=) |
| CA (1) | CA3103231A1 (https=) |
| WO (1) | WO2019241206A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113528510A (zh) | 2018-06-29 | 2021-10-22 | 武汉纽福斯生物科技有限公司 | 治疗遗传性视神经病变的组合物和方法 |
| SG11202101032VA (en) * | 2018-08-20 | 2021-02-25 | Wuhan Neurophth Biotechnology Ltd Company | Compositions and methods for treating leber's hereditary optic neuropathy |
| CN113025633B (zh) | 2019-12-09 | 2024-08-27 | 武汉纽福斯生物科技有限公司 | 编码人nadh脱氢酶亚单位1蛋白的核酸及其应用 |
| CN115710585B (zh) * | 2021-08-23 | 2025-03-28 | 纽福斯(苏州)生物科技有限公司 | 编码nd4的核酸及其用途 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6218117B1 (en) * | 1998-06-15 | 2001-04-17 | Mitokor | Compositions and methods for identifying agents that quantitatively alter detectable extramitochondrial DNA:mitochondrial DNA ratios |
| PT1880008E (pt) * | 2005-05-03 | 2015-08-27 | Inserm Inst Nat De La Santé Et De La Rech Médicale | Expressão de proteína mitocondrial através de uma abordagem alotópica melhorada |
| EP2121914B1 (en) * | 2007-02-16 | 2014-08-20 | John Guy | Mitochondrial nucleic acid delivery systems |
| DE102010013829A1 (de) * | 2010-03-26 | 2011-09-29 | Carl Zeiss Microlmaging Gmbh | Mikroskop und Verfahren zur Erfassung von Probenlicht |
| CN102634527B (zh) * | 2012-04-11 | 2013-11-06 | 华中科技大学同济医学院附属同济医院 | 重组人nadh脱氢酶亚单位4基因及其表达载体构建方法 |
| TWI698240B (zh) * | 2012-05-15 | 2020-07-11 | 澳大利亞商艾佛蘭屈澳洲私營有限公司 | 使用腺相關病毒(aav)sflt-1治療老年性黃斑部退化(amd) |
| KR102244434B1 (ko) * | 2014-08-11 | 2021-04-23 | 삼성전자주식회사 | 재조합 벡터 및 이를 이용한 목적 폴리펩타이드의 생산 방법 |
| CN104450747B (zh) * | 2014-09-23 | 2018-02-09 | 武汉纽福斯生物科技有限公司 | 用于治疗Leber遗传性视神经病变的重组腺相关病毒‑NADH脱氢酶亚单位4基因全长以及药剂 |
-
2019
- 2019-06-11 CA CA3103231A patent/CA3103231A1/en active Pending
- 2019-06-11 JP JP2020569147A patent/JP7470057B2/ja active Active
- 2019-06-11 EP EP19734988.9A patent/EP3802840A1/en active Pending
- 2019-06-11 KR KR1020217000782A patent/KR102946006B1/ko active Active
- 2019-06-11 CN CN201980039197.0A patent/CN112384625A/zh active Pending
- 2019-06-11 US US16/973,900 patent/US20210189424A1/en active Pending
- 2019-06-11 AU AU2019286386A patent/AU2019286386B2/en active Active
- 2019-06-11 WO PCT/US2019/036487 patent/WO2019241206A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7818558B2 (ja) | 修飾された第ｉｘ因子、並びに、細胞、器官及び組織への遺伝子導入のための組成物、方法及び使用 | |
| JP7574508B2 (ja) | 血管系を通過する遺伝子移入の方法および組成物 | |
| US20220331409A1 (en) | Factor ix gene therapy | |
| JP2021526834A5 (https=) | ||
| JP2022068187A (ja) | 抗体回避性ウイルスベクターのための方法および組成物 | |
| JP2020514286A5 (https=) | ||
| JP2022065003A (ja) | パルボウイルスベクターの高められた送達のための改変キャプシドタンパク質 | |
| JP2021534809A (ja) | Ａａｖカプシドの向性の再指向化 | |
| CN104520428B (zh) | 将基因转移到细胞、器官和组织的aav载体组合物和方法 | |
| JP2022500066A5 (https=) | ||
| JP2021502060A5 (https=) | ||
| JP2020510428A5 (https=) | ||
| JP2018537984A5 (https=) | ||
| RU2020137429A (ru) | Лечение пигментного ретинита | |
| TW201706412A (zh) | Ｆａｂｒｙ氏病基因療法 | |
| JP2014507145A (ja) | 改変された形質導入プロファイルを有するウイルスベクターならびにその製造および使用の方法 | |
| PT1127150E (pt) | ''sequências de ácido nucleico do vírus adeno associado do serotipo 1, vectores e células hospedeiras que as contêm'' | |
| JP2022531861A5 (https=) | ||
| JP2019515663A5 (https=) | ||
| AU2020231505A1 (en) | Sequential intravitreal administration of AAV gene therapy to contralateral eyes | |
| MX2023006694A (es) | Tratamiento de la enfermedad de danon. | |
| JP2021510301A5 (https=) | ||
| JP2024119830A5 (https=) | ||
| JP2021533801A5 (https=) | ||
| JP2023040219A5 (https=) |